Regulation of food intake by oleoylethanolamide

Cellular and Molecular Life Sciences

Volumn 62, Issue 6, 2005, Pages 708-716

  Lo Verme, J ^a   Gaetani, S ^a,b   Fu, J ^a   Oveisi, F ^a   Burton, K ^a   Piomelli, D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Energy balance; Feeding; Lipid; Metabolism; Oleoylethanolamide; Palmitoylethanolamide; Peroxisome proliferator activated receptor alpha (PPAR ); Satiety

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; CIGLITAZONE; N OLEOYLETHANOLAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; VANILLOID RECEPTOR;

BODY WEIGHT; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; HYPOPHAGIA; LIPOGENESIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SATIETY; SENSORY NERVE CELL;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; EATING; FEEDING BEHAVIOR; MOLECULAR STRUCTURE; NEURONS, AFFERENT; OLEIC ACIDS; PPAR ALPHA; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; VAGUS NERVE;

EID: 17044393107     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4494-0     Document Type: Review

References (74)

1. Kuehl F. A., Jacob T. A., Ganley O. H., Ormond R. E. and Meisinger, M. A. P. (1957) The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J. Am. Chem. Soc. 79: 5577-5578
2. Bachur N. R., Masek K., Melmon K. L. and Udenfriend S. (1965) Fatty acid amides of ethanolamine in mammalian tissues. J. Biol. Chem. 240: 1019-1024
3. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L A., Griffin G. et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949
4. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J. C. et al. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691
5. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C. and Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564
6. Munro S., Thomas K. L. and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65
7. Piomelli D. (2003) The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4: 873-884
8. Lambert D., Vandevoorde S., Jonsson K. and Fowler J. (2002) The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr. Med. Chem. 9: 663-674
9. Schmid H. H., Schmid P. C. and Natarajan V. (1996) The N-acylation-phosphodiesterase pathway and cell signalling. Chem. Phys. Lipids 80: 133-142
10. Cadas H., Gaillet S., Beltramo M., Venance L. and Piomelli D. (1996) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci. 16: 3934-3942
11. Okamoto Y., Morishita J., Tsuboi K., Tonai T. and Ueda N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279: 5298-5305
12. Sun Y. X., Tsuboi K., Okamoto Y., Tonai T., Murakami M., Kudo I. et al. (2004) Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem J. 380: 749-756
13. Schmid P. C., Zuzarte-Augustin M. L. and Schmid H. H. (1985) Properties of rat liver N-acylethanolamine amidohydrolase. J. Biol. Chem. 260: 14145-14149
14. Cravatt B. F., Giang D. K., Mayfield S. P., Boger D. L., Lerner R. A. and Gilula N. B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87
15. Ueda N., Yamanaka K. and Yamamoto S. (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J. Biol. Chem. 276: 35552-35557
16. Cravatt B. F. and Lichtman A. H. (2002) The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem. Phys. Lipids 121: 135-148
17. Désarnaud F., Cadas H. and Piomelli D. (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 270: 6030-6035
18. Hillard C. J. Wilkison D. M., Edgemond W. S. and Campbell W. B. (1995) Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim. Biophys. Acta 1257: 249-256
19. Ueda N., Kurahashi Y., Yamamoto S. and Tokunaga T. (1995) Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270: 23823-23827
20. Lichtman A. H., Hawkins E. G., Griffin G. and Cravatt B. F. (2002) Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J. Pharmacol. Exp. Ther. 302: 73-79
21. Cravatt B. F., Saghatelian A., Hawkins E. G., Clement A. B., Bracey M. H. and Lichtman A. H. (2004) Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc. Natl. Acad. Sci. USA 101: 10821-10826
22. Hansen H. S., Lauritzen L., Strand A. M., Moesgaard B. and Frandsen A. (1995) Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. Biochim. Biophys. Acta 1258: 303-308
23. Cadas H., di Tomaso E. and Piomelli D. (1997) Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17: 1226-1242
24. Stella N. and Piomelli D. (2001) Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur. J. Pharmacol. 425: 189-196
25. Rodríguez de Fonseca F., Navarro M., Gómez R., Escuredo L., Nava F., Fu J. et al. (2001) An anorexic lipid mediator regulated by feeding. Nature 414: 209-212
26. Ritter R. C. (2004) Gastrointestinal mechanisms of satiation for food. Physiol. Behav. 81: 249-273
27. Fu J., Gaetani S., Oveisi F., Lo Verme J., Serrano A., Rodriguez de Fonseca F. et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425: 90-93
28. Oveisi F., Gaetani S., Eng K. T. and Piomelli D. (2004) Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration. Pharmacol. Res. 49: 461-466
29. Nielsen M. J., Petersen G., Astrup A. and Hansen H. S. (2004) Food intake is inhibited by oral oleoylethanolamide. J. Lipid. Res. 45: 1027-1029
30. McKay B. M. and Ritter R. C. (2004) Oleoylethanolamide induces rapid reduction of short-term food intake in intact and vagotomized rats. Program No. 427.12, Society for Neuroscience, Washington, DC, online
31. Williams C. M. and Kirkham T. C. (1999) Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 143: 315-317
32. Gomez R., Navarro M., Ferrer B., Trigo J. M., Bilbao A., Del Arco I. et al. (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci. 22: 9612-9617
33. Proulx K., Cota D., Woods S. C. and Seeley R. J. (2004) Assessment of the aversive consequences of systemic adminis-tration of oleoylethanolamide in rats. Program No. 147.12, Society for Neuroscience, Washington, DC, online
34. Calignano A., La Rana G., Giuffrida A. and Piomelli D. (1998) Control of pain initiation by endogenous cannabinoids. Nature 394: 277-281
35. Berger J. and Moller D. E. (2002) The mechanisms of action of PPARs. Annu. Rev. Med. 53: 409-435
36. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G. and Wahli W. (1992) Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887
37. Willson T. M., Brown P. J., Sternbach D. D. and Henke B. R. (2000) The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43: 527-550
38. Daynes R. A. and Jones D. C. (2002) Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2: 748-759
39. Wang Y. X., Lee C. H., Tiep S., Yu R. T., Ham J., Kang H. et al. (2003) Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113: 159-170
40. Wang Y. X., Zhang C. L., Yu R. T., Cho H. K., Nelson M. C., Bayuga-Ocampo C. R. et al. (2004) Regulation of muscle fiber type and running endurance by PPAR delta. PLoS Biol 2: e294
41. Picard F. and Auwerx J. (2002) PPAR(gamma) and glucose homeostasis. Annu. Rev. Nutr. 22: 167-197
42. Kersten S. and Wahli W. (2000) Peroxisome proliferator activated receptor agonists. EXS 89: 141-151
43. Nicholl C. G., Polak J. M. and Bloom S. R. (1985) The hormonal regulation of food intake, digestion and absorption. Annu. Rev. Nutr. 5: 213-239
44. Pawar A. and Jump D. B. (2003) Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J. Biol. Chem. 278: 35931-3599
45. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M. G. et al. (1997) Fatty acids, eicosanoids and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11: 779-791
46. Blundell J. E., Burley V. J., Cotton J. R. and Lawton C. L. (1993) Dietary fat and the control of energy intake: evaluating the effects of fat on meal size and postmeal satiety. Am. J. Clin. Nutr. 57: 772S-777S; discussion 777S-778S
47. Lawton C. L., Burley V. J., Wales J. K. and Blundell J. E. (1993) Dietary fat and appetite control in obese subjects: weak effects on satiation and satiety. Int. J. Obes. Relat. Metab. Disord. 17: 409-416
48. Akbiyik F., Cinar K., Demirpence E., Ozsullu T., Tunca R., Haziroglu R. et al. (2004) Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. Eur. J. Clin. Invest. 34: 429-435
49. Schutz Y., Flatt J. P. and Jequier E. (1989) Failure of dietary fat intake to promote fat oxidation: a factor favoring the development of obesity. Am. J. Clin. Nutr. 50: 307-314
50. Bennett C., Reed G. W., Peters J. C., Abumrad N. N., Sun M. and Hill J. O. (1992) Short-term effects of dietary-fat ingestion on energy expenditure and nutrient balance. Am. J. Clin. Nutr. 55: 1071-1077
51. Moreno S., Farioli-Vecchioli S. and Ceru M. P. (2004) Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123: 131-145
52. Ahern G. P. (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J. Biol. Chem. 278: 30429-30434
53. Ross R. A. (2003) Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140: 790-801
54. Grignaschi G., Neill J. C., Petrini A., Garattini S. and Samanin R. (1992) Feeding pattern studies suggest that d-fenfluramine and sertraline specifically enhance the state of satiety in rats. Eur. J. Pharmacol. 211: 137-142
55. Clifton P. G., Lee M. D. and Dourish C. T. (2000) Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat. Psychopharmacology 152: 256-267
56. Ritter R. C., Covasa M. and Matson C. A. (1999) Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight. Neuropeptides 33: 387-399
57. Gaetani S., Oveisi F. and Piomelli D. (2003) Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 28: 1311-1316
58. Schwartz M. W., Woods S. C., Porte D. J., Seeley R. J. and Baskin D. G. (2000) Central nervous system control of food intake. Nature 404: 661-671
59. Janero D. R. (2001) Nutritional aspects of nitric oxide: human health implications and therapeutic opportunities. Nutrition 17: 896-903
60. Calignano A., Persico P., Mancuso F. and Sorrentino J. (1993) Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice. Eur. J. Pharmacol. 231: 415-419
61. Colville-Nash P. R., Qureshi S. S., Willis D. and Willoughby D. A. (1998) Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J. Immunol. 161: 978-984
62. Losel R. and Wehling M. (2003) Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell. Biol. 4: 46-56
63. Chambliss K. L. and Shaul P. W. (2002) Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev. 23: 665-686
64. Chen Z. J., Vetter M., Chang G. D., Liu S., Ding Y. and Chang C. H. (2003) Non-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A. J. Pharm. Pharmacol. 55: 1539-1545
65. Gardner O. S., Dewar B. J., Earp H. S., Samet J. M. and Graves L.M. (2003) Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation. J. Biol. Chem. 278: 46261-46269
66. Guzmán M., Lo Verme J., Fu J., Oveisi F., Blazquez C. and Piomelli D. (2004) Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J. Biol. Chem. 279: 27849-27854
67. Guerre-Millo M. (2003) Extending the glucose/fatty acid cycle: a glucose/adipose tissue cycle. Biochem. Soc. Trans. 31: 1161-1164
68. Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A. et al. (2005) The nuclear receptor PPAR-alpha mediates the antiinflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 67: 15-19
69. Maccarrone M., Cartoni A., Parolaro D., Margonelli A., Massi P., Bari M. et al. (2002) Cannabimimetic activity, binding and degradation of stearoylethanolamide within the mouse central nervous system. Mol. Cell. Neurosci. 21: 126-140
70. Terrazzino S., Berto F., Dalle Carbonare M., Fabris M., Guiotto A., Bernardini D. et al. (2004) Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoylcoenzyme A desaturase-1 mRNA expression. FASEB J. 18: 1580-1582
71. Giuffrida A., Rodríguez de Fonseca F. and Piomelli D. (2000) Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal. Biochem. 280: 87-93
72. Brown P. J., Stuart L. W., Hurley K. P., Lewis M. C., Winegar D. A., Wilson J. G. et al. (2001) Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis. Bioorg. Med. Chem. Lett. 11: 1225-1227
73. Sethi S., Ziouzenkova O., Ni H., Wagner D. D., Plutzky J. and Mayadas T. N. (2002) Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPARalpha. Blood 100: 1340-1346
74. Forman B. M., Chen J. and Evans R. M. (1997) Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA 94: 4312-4317